News

Diabetes education, CGM beyond T1D management, C-peptide levels

Overweight and obesity in T1D, IDF-ATTD joint symposium, presidential takeaways and announcements

Hot from the oven, CGM in T2D, apps in T2D

Beta cell protection in new-onset type 1 diabetes, sleep and glycaemic control, EASD Global Impact Prize

SURPASS-CVOT primary results, technology in pregnancy, how to run a lab

New clinical guideline on diabetes distress, challenges to precision medicine in type 2 diabetes, ketone monitoring & minimum safety for CGM

Precision medicine approaches for monogenic diabetes, CGM in India and in exercise, and the emerging consensus on T1D screening

Early-onset and difficult-to-manage type 2 diabetes, and a new approach to preserve muscle when losing weight

Cardiovascular benefits of oral GLP-1RA, stagnation in HbA1c target achievement, and a paradigm shift in basal insulin therapy

Assessment of hypos revisited, microbes in type 1 diabetes pathogenesis, and a new class of GLP-1 RA

Hot debates on innovations, high-stakes treatment choices, and CGM as OTC 

Cure for type 1 diabetes and key results of the dt-report.

Time in tight range, vision for AID, and obesity management.

Key innovations, screening, and fully-closed loop approaches.